Austria - Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry
Since 2014, Austria Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry grew 2.4% year on year. At $427,223,717.42 Million PPP in 2019, the country was number 15 among other countries in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry. Austria is overtaken by United Kingdom, which was number 14 with $542,693,029.31 Million PPP and is followed by Hungary at $426,636,826.27 Million PPP. United States ranked the highest with $70,565,318,932.39 Million PPP in 2019, that is +3.3% versus 2018. China, Japan and Germany respectively ranked number 2, 3 and 4 in this ranking. Iceland recorded the best 5 years average growth at +43.9% per year, while Lithuania witnessed the worst performance at -42.6% per year.
Loading...
| Date | Million US Dollars PPP |
|---|---|
| 2019 | 427,223,717.42 |
| 2018 | 414,888,616.46 |
| 2017 | 403,228,170.73 |
| 2016 | 388,567,909.05 |
| 2015 | 368,100,947.52 |
How does Austria rank in Business Enterprise Expenditure on R&D Performed in the Pharmaceutical Industry?
| # | 69 Countries | Million US Dollars PPP | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
United States
|
70,565,318,932.39 | 2019 | +3.3 % | +4.5 % | View data | |
| 2 |
#2
China
|
13,956,388,273.35 | 2019 | +4.5 % | +6.1 % | View data | |
| 14 |
#14
United Kingdom
|
542,693,029.31 | 2019 | -1.0 % | -1.1 % | View data | |
| 15 |
#15
Austria
|
427,223,717.42 | 2019 | +3.0 % | +2.4 % | View data | |
| 16 |
#16
Hungary
|
426,636,826.27 | 2019 | +1.7 % | -0.3 % | View data | |